Amylyx Pharmaceuticals, Inc. (AMLX) › EPS (Diluted)Amylyx Pharmaceuticals, Inc. (AMLX) — EPS (Diluted)Annual figures by period end, from SEC filings.2021-12-31: $-13.352022-12-31: $-3.392023-12-31: $0.702024-12-31: $-4.432025-12-31: $-1.53$-1.532021-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-1.53—2026-03-03From 2025-01-012024-12-31$-4.43-732.9%2026-03-03From 2024-01-012023-12-31$0.70—2025-03-04From 2023-01-012022-12-31$-3.39—2024-02-22From 2022-01-012021-12-31$-13.35—2024-02-22From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)